Brief: Abbott Q4 Adjusted EPS USD 1.5 Vs. IBES Estimate USD 1.5
22/01/2026 12:30
Jan 22 (Reuters) - Abbott Q4 EPS USD 1.01. outlook Q1 adjusted EPS USD 1.12-1.18 outlook FY organic growth 6.5-7.5% outlook FY adjusted EPS USD 5.55-5.8
Recent news on Abbott Laboratories
See all newsBrief: FDA Approves Abbott HIV Combo Next Assay
Press Digest: Wall Street Journal - June 29
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports (updated)
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports
Factbox: Major deals involving US drugmakers and biotechs over the past decade